ConductScience.org, home

Paper4108482

[Results of chemotherapy in tuberculosis].

Jancik E. Pneumonologie, 1971. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. [Results of chemotherapy in tuberculosis]. Papers, record 4108482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4108482

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
[Results of chemotherapy in tuberculosis].
PubMed
Journal
Pneumonologie
PubMed
Year
1971
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.13
iCite
Revised in PubMed
2026-10-10
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jancik EE

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antitubercular AgentsMajor topic
TuberculosisMajor topic
Ambulatory Care
Anti-Bacterial Agents
Drug Synergism
Ethambutol
Ethionamide
Female
Humans
Isoniazid
Peptides
Pyrazinamide
Thioacetazone
Tuberculosis, Pulmonary
Tuberculosis, Urogenital
Viomycin

Source PubMed

Download CSV of topics

References146

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15371678[Rifomycin in the treatment of pulmonary tuberculosis: preliminary note].Acta Tuberc Pneumol Belg1969https://conductscience.org/library/papers/5371678PubMed
214327966A CONTROLLED TRIAL OF ISONIAZID AND 4-4 DIISOAMYLOXYTHIOSEMICARBANILIDE COMPARED WITH ISONIAZID AND PAS AND ISONIAZID, STREPTOMYCIN AND PAS.Tubercle1965https://conductscience.org/library/papers/14327966PubMed
313856608PRELIMINARY observations from a controlled trail of prednisolone in the treatment of pulmonary tuberculosis.Am Rev Respir Dis1960https://conductscience.org/library/papers/13856608PubMed
44099678
Isoniazid with thiacetazone (thioacetazone) in the treatment of pulmonary tuberculosis in East Africa--fifth investigation. A co-operative study in East African hospitals, clinics and laboratories with the collaboration of the East African and British Medical Research Councils.
Tubercle1970https://conductscience.org/library/papers/4099678PubMed
54906991[Treatment of chronic tuberculosis with ethambutol and prothionamide associated with rifomycin of capreomycin].Acta Tuberc Pneumol Belg1969https://conductscience.org/library/papers/4906991PubMed
64186789The results from twelve to thirty-six months in patients submitted to two studies of primary chemotherapy for pulmonary tuberculosis in East Africa.Tubercle1969https://conductscience.org/library/papers/4186789PubMed
75371674[Resumption of treatment by rifomycin of resistant cases of pulmonary tuberculosis].Acta Tuberc Pneumol Belg1969https://conductscience.org/library/papers/5371674PubMed
84981497Rifampicin in daily and intermittent treatment of experimental murine tuberculosis, with emphasis on late results.Tubercle1969https://conductscience.org/library/papers/4981497PubMed
95371671Combined treatment with rifampicin-ethambutol-capreomycin in chronic open pulmonary tuberculosis.Acta Tuberc Pneumol Belg1969https://conductscience.org/library/papers/5371671PubMed
104992977Rifampicin in the treatment of experimental tuberculosis in mice: sterilization of tubercle bacilli in the tissues.Tubercle1970https://conductscience.org/library/papers/4992977PubMed
115273218The frequency of postpleuritic tuberculosis.Scand J Respir Dis Suppl1970https://conductscience.org/library/papers/5273218PubMed
124972215Antituberculous activity of rifampin in vitro and in vivo and the concentrations attained in human blood.Am Rev Respir Dis1968https://conductscience.org/library/papers/4972215PubMed
135371670[Rifomycin in continuous and intermittent combined treatment of experimental tuberculosis in mice].Acta Tuberc Pneumol Belg1969https://conductscience.org/library/papers/5371670PubMed
145660491[Fate of patients with "open negative" syndrome].Gruzlica1968https://conductscience.org/library/papers/5660491PubMed
154975543Suitability of isoniazid and ethambutol for intermittent administration in the treatment of tuberculosis.Tubercle1968https://conductscience.org/library/papers/4975543PubMed
165371673Rifampicin in chronic polyresistant cases of pulmonary tuberculosis.Acta Tuberc Pneumol Belg1969https://conductscience.org/library/papers/5371673PubMed
174906103Rifampicin in newly detected, untreated cases of pulmonary tuberculosis.Acta Tuberc Pneumol Belg1969https://conductscience.org/library/papers/4906103PubMed
185785328[Early relapses in inactive pulmonary tuberculosis].Gruzlica1969https://conductscience.org/library/papers/5785328PubMed
194918614"Atypical" mycobacteria: a review.Tubercle1969https://conductscience.org/library/papers/4918614PubMed
2014178620THE TWENTY-THIRD RESEARCH CONFERENCE IN PULMONARY DISEASES OF THE VETERANS ADMINISTRATION-ARMED FORCES.Am Rev Respir Dis1964https://conductscience.org/library/papers/14178620PubMed

See all 146 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4108482

GET https://conductscience.org/api/papers/v1/4108482/references?page=2